SEC Form D · filed January 22, 2025
Indaptus Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (22)
Roger J. Pomerantz · JERUSALEM, L3DirectorAnthony J. Maddaluna · JERUSALEM, L3DirectorRoger J. Waltzman · Austin, TXExecMark J. Gilbert · NEW YORK, NYDirectorMichael J. Newman · San Diego, CAExec · DirectorJeffrey A. Meckler · JERUSALEM, L3Exec · DirectorNir A. Sassi · JERUSALEM, L3ExecWalt A. Linscott · JERUSALEM, L3ExecWilliam B. Hayes · JERUSALEM, L3DirectorHila J. Karah · NEW YORK, NYDirectorRobert E. Martell · NEW YORK, NYDirectorRoger J. Pomerantz · Jupiter, FLDirectorAnthony J. Maddaluna · JERUSALEM, L3DirectorRoger J. Waltzman · Austin, TXExecMark J. Gilbert · NEW YORK, NYDirectorMichael J. Newman · San Diego, CAExec · DirectorJeffrey A. Meckler · JERUSALEM, L3Exec · DirectorNir A. Sassi · JERUSALEM, L3ExecWalt A. Linscott · JERUSALEM, L3ExecWilliam B. Hayes · JERUSALEM, L3DirectorHila J. Karah · NEW YORK, NYDirectorRobert E. Martell · Lexington, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗